Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The US Centres for Medicare and Medicaid Services’ (CMS) proposal to include US-produced domestic nitrile gloves under its payment adjustment scheme from Jan 1, 2026, a decision that is expected to boost demand for US-made nitrile gloves, will benefit Supermax Corp Bhd.
The glovemaker, which recently commissioned its US plant, is said by CIMB Research to gain from the CMS’ proposed modification to include nitrile gloves under its payment adjustment scheme under its Medicare and Medicaid programmes in which buyers would be compensated for the additional costs of purchasing domestically manufactured gloves.